BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29671469)

  • 1. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    Morita H; Komuro I
    N Engl J Med; 2018 Apr; 378(16):1561. PubMed ID: 29671469
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    Nikolaev SI; Fish JE; Radovanovic I
    N Engl J Med; 2018 Apr; 378(16):1561-1562. PubMed ID: 29669234
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
    N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
    Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
    Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
    Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
    Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
    Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
    World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS Activating Signaling Triggers Arteriovenous Malformations.
    Cheng F; Nussinov R
    Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation.
    Priemer DS; Vortmeyer AO; Zhang S; Chang HY; Curless KL; Cheng L
    Hum Pathol; 2019 Jul; 89():33-39. PubMed ID: 31026472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of treatment and therapeutic targets in brain arteriovenous malformation.
    Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
    J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations.
    El Sissy FN; Wassef M; Faucon B; Salvan D; Nadaud S; Coulet F; Adle-Biassette H; Soubrier F; Bisdorff A; Eyries M
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):905-912. PubMed ID: 35238086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
    Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
    Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations.
    Goss JA; Konczyk DJ; Smits PJ; Kozakewich HPW; Alomari AI; Al-Ibraheemi A; Taghinia AH; Dickie BH; Adams DM; Fishman SJ; Mulliken JB; Warman ML; Greene AK
    Angiogenesis; 2019 Nov; 22(4):547-552. PubMed ID: 31486960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriovenous malformation associated with a HRAS mutation.
    Konczyk DJ; Goss JA; Smits PJ; Huang AY; Al-Ibraheemi A; Sudduth CL; Warman ML; Greene AK
    Hum Genet; 2019 Dec; 138(11-12):1419-1421. PubMed ID: 31637524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic GNA11 mutations and a second hit in KRAS in phakomatosis pigmentovascularis are associated with intraosseous arteriovenous malformations in the jaw.
    Sun Y; Su L; Rao Y; Wang Z; Wang D; Fan X; Cai 蔡韧 R
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e484-e486. PubMed ID: 35080323
    [No Abstract]   [Full Text] [Related]  

  • 15. Genotype-guided targeted treatment of KRAS-mutated arteriovenous malformations.
    Cai R; Wang Z; Sun Y; Yang X; Wen M; Zheng L; Wang D; Yu L; Fan X; Su L
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e708-e710. PubMed ID: 35445448
    [No Abstract]   [Full Text] [Related]  

  • 16. Oncogenic activating mutations are associated with local copy gain.
    Modrek B; Ge L; Pandita A; Lin E; Mohan S; Yue P; Guerrero S; Lin WM; Pham T; Modrusan Z; Seshagiri S; Stern HM; Waring P; Garraway LA; Chant J; Stokoe D; Cavet G
    Mol Cancer Res; 2009 Aug; 7(8):1244-52. PubMed ID: 19671679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.
    Bhaumik S; Ahmad F; Das BR
    Med Oncol; 2016 Oct; 33(10):117. PubMed ID: 27637917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆.
    Hames ML; Chen H; Iams W; Aston J; Lovly CM; Horn L
    Lung Cancer; 2016 Feb; 92():29-34. PubMed ID: 26775593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Germline and Somatic Variants Convergently Promote Endothelial-to-Mesenchymal Transition in Simplex Brain Arteriovenous Malformation.
    Li H; Nam Y; Huo R; Fu W; Jiang B; Zhou Q; Song D; Yang Y; Jiao Y; Weng J; Yan Z; Di L; Li J; Wang J; Xu H; Wang S; Zhao J; Wen Z; Wang J; Cao Y
    Circ Res; 2021 Oct; 129(9):825-839. PubMed ID: 34530633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.